510 related articles for article (PubMed ID: 34108450)
1. Interactions between m6A modification and miRNAs in malignant tumors.
Han X; Guo J; Fan Z
Cell Death Dis; 2021 Jun; 12(6):598. PubMed ID: 34108450
[TBL] [Abstract][Full Text] [Related]
2. The role of N
Zhang L; Hou C; Chen C; Guo Y; Yuan W; Yin D; Liu J; Sun Z
Mol Cancer; 2020 Jun; 19(1):105. PubMed ID: 32522202
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of RNA modification N6-methyladenosine in human cancer.
Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
[TBL] [Abstract][Full Text] [Related]
4. The interplay between m6A RNA methylation and noncoding RNA in cancer.
Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
Liang Z; Kidwell RL; Deng H; Xie Q
Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
[TBL] [Abstract][Full Text] [Related]
6. Physio-pathological effects of m6A modification and its potential contribution to melanoma.
Liao Y; Han P; Zhang Y; Ni B
Clin Transl Oncol; 2021 Nov; 23(11):2269-2279. PubMed ID: 34105069
[TBL] [Abstract][Full Text] [Related]
7. The role of m6A RNA methylation in cancer metabolism.
An Y; Duan H
Mol Cancer; 2022 Jan; 21(1):14. PubMed ID: 35022030
[TBL] [Abstract][Full Text] [Related]
8. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
9. m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma.
Zhang QJ; Luan JC; Song LB; Cong R; Ji CJ; Zhou X; Xia JD; Song NH
Exp Cell Res; 2020 Jul; 392(1):112015. PubMed ID: 32333907
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modifications of RNA and their implications in antiviral immunity.
Paramasivam A; Priyadharsini JV
Epigenomics; 2020 Oct; 12(19):1673-1675. PubMed ID: 33078621
[No Abstract] [Full Text] [Related]
11. m6A RNA methylation and beyond - The epigenetic machinery and potential treatment options.
Garbo S; Zwergel C; Battistelli C
Drug Discov Today; 2021 Nov; 26(11):2559-2574. PubMed ID: 34126238
[TBL] [Abstract][Full Text] [Related]
12. Functions of RNA N6-methyladenosine modification in cancer progression.
Chen B; Li Y; Song R; Xue C; Xu F
Mol Biol Rep; 2019 Apr; 46(2):2567-2575. PubMed ID: 30911972
[TBL] [Abstract][Full Text] [Related]
13. Functions of N6-methyladenosine and its role in cancer.
He L; Li H; Wu A; Peng Y; Shu G; Yin G
Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
[TBL] [Abstract][Full Text] [Related]
14. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
Huang W; Chen TQ; Fang K; Zeng ZC; Ye H; Chen YQ
J Hematol Oncol; 2021 Jul; 14(1):117. PubMed ID: 34315512
[TBL] [Abstract][Full Text] [Related]
15. Effects of m6A modifications on signaling pathways in human cancer (Review).
Liu F; Su X
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649845
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.
Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K
Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251
[TBL] [Abstract][Full Text] [Related]
17. Effects of writers, erasers and readers within miRNA-related m6A modification in cancers.
Feng H; Yuan X; Wu S; Yuan Y; Cui L; Lin D; Peng X; Liu X; Wang F
Cell Prolif; 2023 Jan; 56(1):e13340. PubMed ID: 36162823
[TBL] [Abstract][Full Text] [Related]
18. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.
He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L
J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919
[TBL] [Abstract][Full Text] [Related]
19. METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.
Zhang BY; Han L; Tang YF; Zhang GX; Fan XL; Zhang JJ; Xue Q; Xu ZY
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7015-7023. PubMed ID: 32633395
[TBL] [Abstract][Full Text] [Related]
20. Interaction between N
Chen Y; Lin Y; Shu Y; He J; Gao W
Mol Cancer; 2020 May; 19(1):94. PubMed ID: 32443966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
